Eli Lilly and Company News Headlines

LLY 
$63.58
*  
0.02
0.03%
Get LLY Alerts
*Delayed - data as of Sep. 2, 2014 12:38 ET  -  Find a broker to begin trading LLY now
Exchange: NYSE
Industry: Health Care
Community Rating:
View:    LLY Real Time
 
 
Symbol List Views
FlashQuotes InfoQuotes
Stock Details
Summary Quote Real-Time Quote After Hours Quote Pre-market Quote Historical Quote Option Chain
CHARTS
Basic Chart Interactive Chart
COMPANY NEWS
Company Headlines Press Releases Market Stream
STOCK ANALYSIS
Analyst Research Guru Analysis Stock Report Competitors Stock Consultant Stock Comparison
FUNDAMENTALS
Call Transcripts Annual Report Income Statement Revenue/EPS SEC Filings Short Interest Dividend History
HOLDINGS
Ownership Summary Institutional Holdings Insiders
(SEC Form 4)
 Save stocks for next time
Viewing
Filtered By
Ordered By

3 Reasons Eli Lilly & Co.'s Stock Could Rise
9/2/2014 10:00:17 AM - Motley Fool

Eli Lilly-Boehringer Drug's Cost Effectiveness Questioned - Analyst Blog
8/29/2014 4:30:00 PM - Zacks.com

3 Reasons for Rite Aid Corporation's Resurgence
8/28/2014 1:08:07 PM - Motley Fool

Lilly's Returning Cash to Shareholders With Generous Dividend, Stock Buybacks
8/28/2014 10:16:00 AM - TheStreet

Can You Live Off Of Dividend Growth Income In Retirement?
8/27/2014 6:55:00 PM - Seeking Alpha

Will This New Rating Help Eli Lilly (LLY) Stock Today?
8/27/2014 9:03:00 AM - TheStreet

Alkermes Gains on Aripiprazole Lauroxil NDA Submission - Analyst Blog
8/26/2014 7:00:00 PM - Zacks.com

Lilly, Boehringer Say Jardiance Tablets For Type 2 Diabetes Available In U.S.
8/26/2014 9:18:00 AM - RTT News

Eli Lilly Uncovers Positive Data from Ixekizumab Studies - Analyst Blog
8/22/2014 5:45:00 PM - Zacks.com

Bristol-Myers, Celgene Pair Up for Oncology Combo Treatments - Analyst Blog
8/21/2014 5:20:00 PM - Zacks.com

Lilly Says Ixekizumab Superior To Etanercept/Placebo In Phase 3 Psoriasis Study
8/21/2014 10:07:00 AM - RTT News

Lilly:Ixekizumab Superior To Etanercept &Placebo In Late-stage Psoriasis Studies
8/21/2014 7:29:00 AM - RTT News

5 Things Eli Lilly and Co's Management Wants You to Know
8/20/2014 5:59:28 PM - Motley Fool

GlaxoSmithKline: The Bad Isn't All That Bad
8/20/2014 3:39:00 PM - Seeking Alpha

How To Avoid The Worst Style ETFs
8/20/2014 9:49:00 AM - Seeking Alpha

Eli Lilly-Boehringer's Insulin Drug Gets Tentative FDA Nod - Analyst Blog
8/19/2014 1:10:00 PM - Zacks.com

Today's Market: News, Earnings And Housing Data Pushing These Stocks Higher
8/19/2014 10:00:00 AM - Seeking Alpha

Wall Street On Track To Sustain Upward Momentum
8/19/2014 6:30:00 AM - RTT News

Kindred 30.33% Upside Paced Healthcare August Dividend Dogs
8/18/2014 9:18:00 PM - Seeking Alpha

FDA Grants Tentative Approval For Lilly And Boehringer Ingelheim's Basaglar
8/18/2014 8:05:00 PM - RTT News

Eli Lilly: FDA Grants Tentative Approval For Insulin Drug Basaglar
8/18/2014 7:36:00 PM - RTT News

Eli Lilly: Strong Future Prospects Will Restore The Company's Financials
8/18/2014 8:04:00 AM - Seeking Alpha

2 Stocks With Million Dollar Insider Purchases In 2014
8/14/2014 11:24:00 AM - Seeking Alpha

Biodel Q3 Loss Narrower than Expected, Gives Pipeline Update - Analyst Blog
8/14/2014 10:58:00 AM - Zacks.com

Why The Sanofi Deal Is The Best Possible Deal For MannKind Investors
8/11/2014 1:09:00 PM - Seeking Alpha